Clinical Pediatric Dermatology Open Access

  • ISSN: 2472-0143
  • Journal h-index: 3
  • Journal CiteScore: 0.79
  • Journal Impact Factor: 0.16
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Abstract

Wound Congress & Clinical Dermatology Congress 2018: Topical medical cannabis: A new epigenetic paradigm for wound management - Vincent Maida - William Osler Health System

Vincent Maida 

Introduction: During skin aging, cumulative photo damage, exhaustion of endogenous stem cell populations, mechanical stress, and increased fibrosis lead to skin with decreased epidermal thickness and compromised dermal integrity (Maciej Nowacki et al, 2018). Stem cell-based therapies have been widely used for their abilities to repair and regenerate different types of tissues and organs in cosmetic and plastic surgeries. Despite the fact, that most treatments involving stem cells are new and have very little evidence based efficacy, stem cell treatments for skin rejuvenation are already being hailed as the preferred method by which to perform a facelift non-surgically (Odunze M et al 2011). Mesenchymal stem cells (MSCs) seem to be an ideal source for tissue engineering application due to the lack of ethical concerns, high availability and increasing number of methods for isolation and expansion of such cell types (Davood Mehrabani et al).